Sunshine Biopharma Inc. last reported quarterly results on Apr 9, 2026, for Q1 FY2026 (the quarter ended Mar 31, 2026): revenue of $8.1 million (-9.1% year over year). It usually reports 2–50 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 2–50 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Apr 9, 2026
9 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
8
-9.1%
|
-1
-5.4%
|
—
|
|
Apr 2, 2025
2 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
9
+18.0%
|
-1
+8.1%
|
-0.44
+78.0%
|
|
Nov 7, 2024
38 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
8
+41.6%
|
-1
-83.9%
|
-0.94
+98.1%
|
|
Aug 19, 2024
50 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
Apr 1, 2024
1 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
|
Nov 13, 2023
44 days after quarter end
|
—
ended Sep 30, 2023
|
—
|
—
|
—
|
|
Aug 11, 2023
42 days after quarter end
|
—
ended Jun 30, 2023
|
—
|
—
|
—
|
|
May 11, 2023
41 days after quarter end
|
—
ended Mar 31, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SBFM (Nasdaq), SBFMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1402328
- Former names
- Sunshine Biopharma, Inc (until Oct 17, 2024); Mountain West Business Solutions, Inc (until Nov 2, 2009); mountain west business solutions,inc (until Oct 19, 2007); mountain state business solutions,inc (until May 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.